| Expression pattern: |
UP |
| Associated gene: |
CDK6 |
| Associated microRNA: |
miR-299-3p |
| Biological function: |
Circ_OSBPL10 promotes OSCC cell proliferation, cell cycle progression, colony formation, migration, invasion and tumor growth, and inhibits apoptosis; silencing circ_OSBPL10 suppresses these malignant behaviors and diminishes tumor growth in vivo. |
| Molecular mechanism: |
Circ_OSBPL10 functions as a competing endogenous RNA for miR-299-3p to regulate CDK6 expression, thereby affecting OSCC cell functional behaviors. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); cell cycle (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Transfection; MTT; Colony Formation Assay; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; Western Blot; In Vivo Animal Model |
| Clinical significance: |
circ_OSBPL10 is highlighted as a promising therapeutic target for OSCC. |
| Description: |
circ_OSBPL10 is up-regulated in OSCC tissues and cells and functions as an oncogenic circRNA. It promotes proliferation, cell-cycle progression, colony formation, migration, invasion and in vivo tumor growth while suppressing apoptosis, at least partly through the circ_OSBPL10/miR-299-3p/CDK6 ceRNA axis. The study proposes circ_OSBPL10 inhibition as a potential therapeutic strategy for OSCC. |
| Confidence score: |
0.7183 |